News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

U.S. Supreme Court Refuses To Hear Ex-InterMune, Inc. (ITMN) CEO's Appeal


12/16/2013 8:13:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The U.S. Supreme Court on Monday said it would not review the fraud conviction of former InterMune Inc Chief Executive Scott Harkonen for a statement he made about the effectiveness of one of the company's drugs. Harkonen was prosecuted by the U.S. Justice Department for promoting the use of Actimmune as a treatment for idiopathic pulmonary fibrosis, a lung disease, in a news release the company issued in 2002. The U.S. Food and Drug Administration had not approved the drug for that purpose.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at BusinessWeek
Read at Washington Post


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES